Shu-Bin Guo

Prof. Dr. Shu-Bin Guo

Beijing Chao-Yang Hospital, Capital Medical University
+1

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JLJunyu Li
Junyu Li
HLHuizhen Liu
Huizhen Liu
NWNa Wang
Na Wang
FWFengrong Wang
Fengrong Wang
NSNa Shang
Na Shang
GWGuodong Wang
Guodong Wang
Background: The performance of the sepsis-induced coagulopathy (SIC) and sequential organ failure assessment (SOFA) scores in predicting the prognoses of patients with sepsis has been validated. This study aimed to investigate the time course of SIC and SOFA scores and their association with outcomes in patients with sepsis. Methods: This prospective study enrolled 209 patients with sepsis admitted to the emergency department. The SIC and SOFA scores of the patients were assessed on days 1, 2, and 4. Patients were categorized into survivor or non-survivor groups based on their 28-day survival. We conducted a generalized estimating equation analysis to evaluate the time course of SIC and SOFA scores and the corresponding differences between the two groups. The predictive value of SIC and SOFA scores at different time points for sepsis prognosis was evaluated. Results: In the non-survivor group, SIC and SOFA scores gradually increased during the first 4 days (P < 0.05). In the survivor group, the SIC and SOFA scores on day 2 were significantly higher than those on day 1 (P < 0.05); however, they decreased on day 4, dropping below the levels observed on day 1 (P < 0.05). The non-survivors showed higher SIC scores on days 2 (P < 0.05) and 4 (P < 0.001) than the survivors, whereas no significant differences were found between the two groups on day 1 (P > 0.05). The performance of SIC scores on day 4 for predicting mortality was more accurate than that on day 2, with areas under the curve of 0.749 (95% confidence interval [CI]: 0.674–0.823), and 0.601 (95% CI: 0.524–0.679), respectively. The SIC scores demonstrated comparable predictive accuracy for 28-day mortality to the SOFA scores on days 2 and 4. Cox proportional hazards models indicated that SIC on day 4 (hazard ratio [HR] = 3.736; 95% CI: 2.025–6.891) was an independent risk factor for 28-day mortality. Conclusions: The time course of SIC and SOFA scores differed between surviving and non-surviving patients with sepsis, and persistent high SIC and SOFA scores can predict 28-day mortality.

27 May 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
QLQiujing Li
Qiujing Li
NSNa Shang
Na Shang
QGQian Gao
Qian Gao
SGShu-Bin Guo
Shu-Bin Guo
TYTiecheng Yang
Tiecheng Yang
Studies on the prevalence of sarcopenia and its relationship with other geriatric syndromes among older patients with sepsis in the emergency department (ED) are scarce. This study aimed to investigate the prevalence of sarcopenia among older patients with sepsis and explore its association with specific geriatric symptoms: frailty and malnutrition. This cross-sectional study was carried out in China from January to November 2022. Muscle mass, as indicated by the skeletal muscle index (SMI) was measured using abdominal plain computed tomography. Sarcopenia, frailty, and nutritional status were defined according to the Asian Working Group for Sarcopenia 2019 criteria, Clinical Frailty Scale (CFS) score, and Mini Nutritional Assessment-Short Form (MNA-SF) score. The correlations of the SMI with the CFS and MNA-SF scores were analyzed using nonparametric Spearman correlation analysis. Univariate and multivariable logistic regression analyses were performed to determine the associations of sarcopenia with frailty and malnutrition. A total of 602 patients (332 men; median age, 78 years; median body mass index, 23.1 kg/m2) were included. Sarcopenia, frailty, and malnutrition were present in 36.2%, 58.0%, and 34.6% of the patients, respectively. Of the 602 patients, 414 (68.8%) had at least one geriatric syndrome, 253 (42.0%) had at least two simultaneously. The SMI correlated negatively with the CFS score and positively with the MNA-SF score (all p < 0.001). The CFS (adjusted odds ratio [OR] = 1.384 per 1-point increase, p < 0.001) and MNA-SF (adjusted OR = 0.887 per 1-point increase, p = 0.002) scores were independently associated with sarcopenia. Frailty (adjusted OR = 3.816, p = 0.003), being at risk of malnutrition (adjusted OR = 2.466, p = 0.001), and being malnourished (adjusted OR = 2.477, p = 0.002) were independently associated with sarcopenia. Sarcopenia and coexisting geriatric syndromes were prevalent and interrelated among older patients with sepsis in EDs. Clinicians should assess older patients with sepsis for geriatric syndromes to provide them with more accurate interventions. This study was registered at www.chictr.org.cn (registration number: ChiCTR2300070377, date: 11–04-2023).

30 September 2023 in Inflammation
Verified
Journal Article
Open access
PDF file
LYLi Yang
Li Yang
QGQian Gao
Qian Gao
QLQiujing Li
Qiujing Li
SGShu-Bin Guo
Shu-Bin Guo
Monocyte dysfunction is critical to sepsis-induced immunosuppression. Programmed death ligand-1 (PD-L1) has shown a close relationship with inflammatory disorder among animal models and patients. We aimed to investigate the potential beneficial immunologic mechanisms of anti-PD-L1 on monocyte dysfunction of mice with sepsis. Firstly, we assessed the potential association between PD-L1 expression on monocyte subsets and sepsis severity as well as 28-day mortality. In this study, 52 septic patients, 28 septic shock patients, and 40 healthy controls were enrolled and their peripheral whole blood was examined by flow cytometry. Then, cecal ligation and puncture (CLP) were performed for establishing the mouse sepsis model. Subsequently, effects of anti-PD-L1 antibody on monocyte subset, major histocompatibility complex II (MHC II) expression, cytokine production, and survival were investigated. PD-L1 expression on the classical monocytes (CD14 + + CD16 −) was significantly upregulated among septic shock patients and the 28-day death group than non-septic shock group and 28-day survival group (P < 0.05). Compared to septic mice, anti-PD-L1-treated mice had significantly elevated percentages of major histocompatibility complex (MHC) II on peripheral Ly6chi monocyte at 24 h after CLP. Our results showed that the anti-PD-L1 antibody markedly decreased the level of serum inflammatory cytokines interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-10 in sepsis mice at 24 h, 48 h, and 72 h, respectively (P < 0.05). The survival rate of CLP mice was significantly improved by anti-PD-L1 antibody treatment. Classical monocytes with high expression of PD-L1 were thought to be connected with sepsis progression. The PD-L1 blockade protects from sepsis, at least partially by inhibiting the reversal of monocyte dysfunction.

18 July 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
QLQi Liu
Qi Liu
XZXiaomei Zhu
Xiaomei Zhu
SGShu-Bin Guo
Shu-Bin Guo
Background: Severe acute pancreatitis (SAP) is a potentially lethal inflammatory pancreatitis condition that is usually linked to multiple organ failure. When it comes to SAP, the lung is the main organ that is frequently involved. Many SAP patients experience respiratory failure following an acute lung injury (ALI). Clinicians provide insufficient care for compounded ALI since the underlying pathophysiology is unknown. The mortality rate of SAP patients is severely impacted by it.Objective: The study aims to provide insight into immune cells, specifically their roles and modifications during SAP and ALI, through a comprehensive literature review. The emphasis is on immune cells as a therapeutic approach for treating SAP and ALI.Findings: Immune cells play an important role in the complicated pathophysiology ofSAP and ALI by maintaining the right balance of pro‐ and anti‐inflammatory responses. Immunomodulatory drugs now in the market have low thepeutic efficacy because they selectively target one immune cell while ignoring immune cell interactions. Accurate management of dysregulated immune responses is necessary. A critical initial step is precisely characterizing the activity of the immune cells during SAP and ALI.Conclusion: Given the increasing incidence of SAP, immunotherapy is emerging as a potential treatment option for these patients. Interactions among immune cells improve our understanding of the intricacy of concurrent ALI in SAP patients. Acquiring expertise in these domains will stimulate the development of innovative immunomodulation therapies that will improve the outlook for patients with SAP and ALI.

3 October 2023 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
SWShuxing Wei
Shuxing Wei
YZYongsheng Zhang
Yongsheng Zhang
HDHongmeng Dong
Hongmeng Dong
YCYing Chen
Ying Chen
XWXiya Wang
Xiya Wang
SGShu-Bin Guo
Shu-Bin Guo
Background: Acute kidney injury (AKI) can make cases of acute respiratory distress syndrome (ARDS) more complex, and the combination of the two can significantly worsen the prognosis. Our objective is to utilize machine learning (ML) techniques to construct models that can promptly identify the risk of AKI in ARDS patients. Method: We obtained data regarding ARDS patients from the Medical Information Mart for Intensive Care III (MIMIC-III) and MIMIC-IV databases. Within the MIMIC-III dataset, we developed 11 ML prediction models. By evaluating various metrics, we visualized the importance of its features using Shapley additive explanations (SHAP). We then created a more concise model using fewer variables, and optimized it using hyperparameter optimization (HPO). The model was validated using the MIMIC-IV dataset. Result: A total of 928 ARDS patients without AKI were included in the analysis from the MIMIC-III dataset, and among them, 179 (19.3%) developed AKI after admission to the intensive care unit (ICU). In the MIMIC-IV dataset, there were 653 ARDS patients included in the analysis, and among them, 237 (36.3%) developed AKI. A total of 43 features were used to build the model. Among all models, eXtreme gradient boosting (XGBoost) performed the best. We used the top 10 features to build a compact model with an area under the curve (AUC) of 0.850, which improved to an AUC of 0.865 after the HPO. In extra validation set, XGBoost_HPO achieved an AUC of 0.854. The accuracy, sensitivity, specificity, positive prediction value (PPV), negative prediction value (NPV), and F1 score of the XGBoost_HPO model on the test set are 0.865, 0.813, 0.877, 0.578, 0.957 and 0.675, respectively. On extra validation set, they are 0.724, 0.789, 0.688, 0.590, 0.851, and 0.675, respectively. Conclusion: ML algorithms, especially XGBoost, are reliable for predicting AKI in ARDS patients. The compact model maintains excellent predictive ability, and the web-based calculator improves clinical convenience. This provides valuable guidance in identifying AKI in ARDS, leading to improved patient outcomes.

30 August 2022 in Geriatrics & Gerontology International
Verified
Journal Article
Open access
NSNa Shang
Na Shang
HLHuizhen Liu
Huizhen Liu
NWNa Wang
Na Wang
SGShu-Bin Guo
Shu-Bin Guo
LMLina Ma
Lina Ma
Aim: To compare the predictive abilities of the FRAIL scale (FS), frailty screening questionnaire (FSQ) and clinical frailty scale (CFS) for adverse outcomes in older adults in the emergency department.Methods: In total, 317 older adults aged ≥65 years attending emergency department was screened for frailty using the FS, FSQ and CFS. Outcome measures included all‐cause 28‐day mortality and intensive care unit readmission. Cox proportional hazards model was used for survival comparison. Logistic regression was used to analyze risk factors for readmissions. In addition, we calculated the C‐statistic, net reclassification improvement and integrated discrimination improvement to evaluate the predictive value of three scales.Results: The prevalence of frailty was 55.2% (FS), 47.0% (FSQ) and 69.4% (CFS). Cox regression and logistic regression analysis revealed that frailty screening by FS, FSQ and CFS was an independent risk factor for all‐cause 28‐day mortality and 30‐ and 90‐day readmission after adjustment. Incorporation of FS, FSQ and CFS into a basic model with other risk factors significantly improved C‐statistic. For all‐cause 28‐day mortality, the model including FS had the highest C‐statistic from 0.786 (95% confidence interval: 0.706–0.865) to 0.854 (95% confidence interval: 0.802–0.907) and the improvements in risk prediction were also confirmed by category‐free net reclassification improvement and integrated discrimination improvement, suggesting FS was significantly better than CFS and FSQ. The three tools had a low predictive ability for readmission (all C‐statistics <0.7).Conclusions: All three frailty scales showed a predictive ability for 28‐day mortality and readmission but FS may be the most valid tool in the emergency department. Geriatr Gerontol Int ••; ••: ••–•• Geriatr Gerontol Int 2022; 22: 851–856.